Additional evidences has also been suggesting that cytotoxic chemotherapy is more effective among patients with high EGFR expression than in those with low EGFR expression in non-small-cell lung cancer (NSCLC) and colorectal cancer (CRC), respectively [28,29]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.